Ohcanbohtosat - Lomas DA

Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis Dahkki Dickens JA, Lomas DA

Viečča ollesdeavstta

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial Dahkki Ismaila AS, Risebrough N, Schroeder M, Shah D, Martin A, Goodall EC, Ndirangu K, Criner G, Dransfield M, Halpin DMG, Han MK, Lomas DA

Viečča ollesdeavstta

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency Dahkki Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR

Viečča ollesdeavstta